April 08, 2025 11:25 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
CJI Sanjiv Khanna to decide on listing pleas challenging Waqf (Amendment) Act | Mamata Banerjee backs Bengal teachers who lost jobs, says she has plans to accommodate them | Drunk filmmaker Siddhant Das rams car into Kolkata market, one killed, several injured | Kunal Kamra moves Bombay High Court, seeks quashing of FIR over Eknath Shinde parody | Amit Shah briefs BJP MLAs in his three-day Jammu and Kashmir visit | Bengal BJP leaders participate in Ram Navami rallies across state | PM Modi to inaugurate new Pamban Rail Bridge, connecting Rameswaram to Indian mainland, today | Huge protests erupt in Kolkata, Chennai after parliament passes Waqf Amendment Bill | India’s growth outlook dims after US tariffs; deeper rate cuts likely, say analysts: Report | K Annamalai says he is not in a race to become Tamil Nadu BJP's next president
SII buys 50 pc stake in pharma packaging firm Schott Kaisha

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

Aug 18, 2021, at 06:41 am

Pune/IBNS: Pune-based manufacturer of AstraZeneca vaccine, Covishield, Serum Institute of India (SII) has acquired a 50 per cent stake in SCHOTT Kaisha to become SCHOTT's joint venture partner and secure the pharma packaging supply, the pharma company announced on Tuesday.

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

May 04, 2021, at 05:09 pm

London: British PM Boris Johnson has announced the Serum Institute of India (SII), the manufacturers of COVID-19 vaccine Covishield, will be investing 240 million pounds in the United Kingdom through the opening of a new sales office, media reports said.

Close menu